Enzymotec
A developer, manufacturer and marketer of innovative bio-active lipid ingredients and nutritional products.
Launch date
Market cap
-
Enterprise valuation
AUD448m (Public information from Oct 2017)
Migdal HaEmek North District (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$11.0m | Series B | ||
N/A | - | ||
$10.0m | Series B | ||
| N/A | N/A | IPO | |
* | $210m Valuation: $290m | Acquisition | |
| Total Funding | AUD32.5m | ||
Related Content
Recent News about Enzymotec
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.